Cerenome, Inc. (CNSY)
NASDAQ: CNSY · Real-Time Price · USD
3.730
+0.030 (0.81%)
Aug 14, 2026, 2:23 PM EDT - Market open

Cerenome Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
5.185.215.824.910.22-
Revenue Growth
-0.46%-10.49%18.54%2093.30%--
Gross Profit
-4.31-3.17-4.76-4.78-9.47-5.32
Operating Income
-18.88-15.3-14.7-13.32-19.71-12.18
Net Income
-11.93-22.39-12.98-13.32-20.28-13.4
Earnings Per Share
-2.62-7.25-58.52-106.00-289.58-416.25
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
15.118.613.618.5518.1218.4
Total Debt
0.730.823.374.185.656.99
Net Cash (Debt)
14.397.790.244.3712.4811.41
Net Cash Growth
46.42%3159.83%-94.53%-64.95%9.36%744.96%
Net Cash Per Share
3.112.500.7834.81178.18353.84

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-20.84-20.78-10.55-12.85-12.97-10.28
Capital Expenditures
-0.88-0.07-0.15-0.16-0.51-0.14
Free Cash Flow
-21.72-20.84-10.7-13.01-13.48-10.42
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
-83.09%-60.73%-81.66%-97.23%--
Operating Margin
-364.36%-293.46%-252.32%-271.14%-8800.00%-
Pretax Margin
-230.24%-429.43%-222.84%-271.04%-9051.34%-
Profit Margin
-230.24%-429.43%-222.84%-271.04%-9051.34%-
FCF Margin
-419.20%-399.81%-183.72%-264.83%-6018.30%-

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
-2.562.562.562.562.56
PS Ratio
4.7213.511.161.6147.55-